سعر جاتيستار 0.5% قطرة عين 5 مل 2025

Gatifloxacin 0.5% ophthalmic solution, 5 ml bottle, by Orchidia Pharmaceutical Industries.

• Bacterial conjunctivitis caused by susceptible strains of the organisms listed in the label.Population: Adults and children 1 year and olderDailyMed (U.S. National Library of Medicine)

• Most frequent adverse reactions (at least 1%) with ZYMAXID: worsening of the conjunctivitis, eye irritation, dysgeusia and eye pain.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to gatifloxacin, to other quinolones, or to any component of the medication.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity reactions, including anaphylactic reactions, angioedema, dyspnea, urticaria and itching (even after a single dose) and rare Stevens-Johnson syndrome, have been reported with topical ophthalmic gatifloxacin; discontinue if an allergic reaction occurs. Prolonged use may result in overgrowth of nonsusceptible organisms, including fungi. Corneal endothelial cell injury is listed as a serious adverse reaction (not for introduction into the anterior chamber).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• No available data in pregnant women; oral gatifloxacin in pregnant rats and rabbits did not produce adverse developmental outcomes at clinically relevant doses (teratogenic effects in rats only at doses about 600-fold the maximum recommended human ophthalmic dose).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No information on presence in human milk or effects on the breastfed infant; gatifloxacin was found in rat milk after oral dosing, but systemic levels after topical ocular use are low.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Gatifloxacin: Fluoroquinolone antibacterial; inhibits bacterial DNA gyrase and topoisomerase IV (US label).